Natalie J. Ayoub
FDA investigator
Appears on 3 documents from 2016 to 2017, mostly at sites in California. Most often cites review of ongoing investigations (21 CFR 312.56(a)).
- 3
- Documents on file
- 7.0
- Observations per 483
- 2016
- First seen
- 2017
- Most recent
What they cite most
From 7 observations- 21 CFR 312.56(a)Review of ongoing investigations2
- 21 CFR 312.62(a)Investigator recordkeeping and record retention2
- 21 CFR 312.60General responsibilities of investigators1
- 21 CFR 312.66Assurance of IRB review1
- 21 CFR 50.25(c)Elements of informed consent1
Activity by year
2016: 2, 2017: 1
Where
California 3
Is Natalie J. Ayoub coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
3 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2017-01-05 | Warning letter Warning letter · FEI 3012242764Jan 5, 2017 · La Jolla, California | La Jolla, California | — | |
| 2016-08-25 | EIR EIR · FEI 3012242764Aug 25, 2016 · La Jolla, California | La Jolla, California | — | |
| 2016-08-01 | 483 Kang Zhang, M.D., Ph.DAug 1, 2016 · La Jolla, California | La Jolla, California | 7 |
About this profile
What does Natalie J. Ayoub inspect?
Natalie J. Ayoub appears on 3 documents on file covering 1 site, mostly in California.
What do they cite most often?
21 CFR 312.56(a) (review of ongoing investigations), followed by 21 CFR 312.62(a) and 21 CFR 312.60.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Natalie J. Ayoub is dated Jan 5, 2017.